Sysmex (OTCMKTS:SSMXY) Sees Strong Trading Volume – Here’s Why

Sysmex Corporation ADR (OTCMKTS:SSMXY) shares saw strong trading volume on Monday. 229,861 shares changed hands during mid-day trading, an increase of 27% from the previous session’s volume of 180,761 shares. The stock last traded at $12.03 and had previously closed at $12.13.

Analyst Ratings Changes

Separately, Zacks Research raised Sysmex from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 18th. One research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold”.

Sysmex Stock Performance

The company has a market capitalization of $7.45 billion, a PE ratio of 28.19 and a beta of 1.09. The stock’s fifty day simple moving average is $11.41 and its 200-day simple moving average is $9.75. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.53 and a current ratio of 3.40.

Sysmex (OTCMKTS:SSMXY) last issued its quarterly earnings results on Friday, August 7th. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.07 by $0.02. Sysmex had a return on equity of 8.01% and a net margin of 7.62%.The company had revenue of $825.85 million during the quarter, compared to the consensus estimate of $741.67 million. Sysmex has set its FY 2026 guidance at 0.382-0.382 EPS. As a group, equities analysts predict that Sysmex Corporation ADR will post 0.42 earnings per share for the current year.

Sysmex Company Profile

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and sells diagnostic instruments, reagents and related information systems. Its products are primarily used in clinical laboratories, hospitals and other healthcare settings to support the analysis of blood, urine and other biological samples.

The company is best known for its hematology testing systems, including automated analyzers used to assess blood cell counts and related parameters. Its portfolio also includes products for hemostasis and coagulation testing, urinalysis, clinical chemistry, immunochemistry and flow cytometry, as well as laboratory information systems, maintenance and other support services.

Sysmex was established in 1968 and is headquartered in Kobe, Japan.